【レポートの概要(一部)】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Targeted therapy – Market size and forecast 2018-2023
• Chemotherapy – Market size and forecast 2018-2023
• Immunotherapy – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Emergence of pipeline molecules
• Development of diagnostic tests and predictive markers
• Increasing research in regenerative medicines
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Targeted therapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Targeted therapy – Year-over-year growth 2019-2023 (%)
Exhibit 22: Chemotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Chemotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 24: Immunotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Immunotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Boehringer Ingelheim International GmbH – Vendor overview
Exhibit 51: Boehringer Ingelheim International GmbH – Product segments
Exhibit 52: Boehringer Ingelheim International GmbH – Organizational developments
Exhibit 53: Boehringer Ingelheim International GmbH – Geographic focus
Exhibit 54: Boehringer Ingelheim International GmbH – Segment focus
Exhibit 55: Boehringer Ingelheim International GmbH – Key offerings
Exhibit 56: Boehringer Ingelheim International GmbH – Key customers
Exhibit 57: Bristol-Myers Squibb Co. – Vendor overview
Exhibit 58: Bristol-Myers Squibb Co. – Product segments
Exhibit 59: Bristol-Myers Squibb Co. – Organizational developments
Exhibit 60: Bristol-Myers Squibb Co. – Geographic focus
Exhibit 61: Bristol-Myers Squibb Co. – Key offerings
Exhibit 62: Bristol-Myers Squibb Co. – Key customers
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Product segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 70: Merck & Co. Inc. – Vendor overview
Exhibit 71: Merck & Co. Inc. – Product segments
Exhibit 72: Merck & Co. Inc. – Organizational developments
Exhibit 73: Merck & Co. Inc. – Geographic focus
Exhibit 74: Merck & Co. Inc. – Segment focus
Exhibit 75: Merck & Co. Inc. – Key offerings
Exhibit 76: Merck & Co. Inc. – Key customers
Exhibit 77: Mylan NV – Vendor overview
Exhibit 78: Mylan NV – Product segments
Exhibit 79: Mylan NV – Organizational developments
Exhibit 80: Mylan NV – Geographic focus
Exhibit 81: Mylan NV – Segment focus
Exhibit 82: Mylan NV – Key offerings
Exhibit 83: Mylan NV – Key customers
Exhibit 84: Novartis AG – Vendor overview
Exhibit 85: Novartis AG – Product segments
Exhibit 86: Novartis AG – Organizational developments
Exhibit 87: Novartis AG – Geographic focus
Exhibit 88: Novartis AG – Segment focus
Exhibit 89: Novartis AG – Key offerings
Exhibit 90: Novartis AG – Key customers
Exhibit 91: Otsuka Holdings Co. Ltd. – Vendor overview
Exhibit 92: Otsuka Holdings Co. Ltd. – Product segments
Exhibit 93: Otsuka Holdings Co. Ltd. – Organizational developments
Exhibit 94: Otsuka Holdings Co. Ltd. – Geographic focus
Exhibit 95: Otsuka Holdings Co. Ltd. – Segment focus
Exhibit 96: Otsuka Holdings Co. Ltd. – Key offerings
Exhibit 97: Otsuka Holdings Co. Ltd. – Key customers
Exhibit 98: Pfizer Inc. – Vendor overview
Exhibit 99: Pfizer Inc. – Product segments
Exhibit 100: Pfizer Inc. – Organizational developments
Exhibit 101: Pfizer Inc. – Geographic focus
Exhibit 102: Pfizer Inc. – Segment focus
Exhibit 103: Pfizer Inc. – Key offerings
Exhibit 104: Pfizer Inc. – Key customers
Exhibit 105: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 106: Takeda Pharmaceutical Co. Ltd. – Product segments
Exhibit 107: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 108: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 109: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 110: Takeda Pharmaceutical Co. Ltd. – Key customers
Exhibit 111: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 112: Teva Pharmaceutical Industries Ltd. – Product segments
Exhibit 113: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 114: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 115 Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 116: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル:慢性骨髄性白血病治療法の世界市場2019-2023■ 英文:Chronic Myelogenous Leukemia Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日:2019年8月28日
■ 調査会社:Technavio
■ 商品コード:IRTNTR31940
■ 調査対象地域:グローバル、アジア太平洋、ヨーロッパ、北米、その他
- 世界のグレープシードオイル市場:種類別、地域別Global Grape Seed Oil Market: About this market Technavio’s grape seed oil market analysis considers sales from mechanical extraction and chemical extraction types. Our study also finds the sales of grape seed oil in APAC, Europe, MEA, North America, and South America. In 2019, the mechanical extraction segment had a significant market share, and this trend is expected to continue over the forecas …
- 五酸化二リンの世界市場2015Phosphorpentoxid (CAS 1314-56-3) Market Research Report 2015 aims at providing comprehensive data on Phosphorpentoxid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Phosphorpentoxid description, covers its application areas, manufacturing methods, patterns. It captures Phosphorpentoxid market trends, pays close attention to Phosphorpentoxid man …
- 世界の公共安全LTE市場:インフラストラクチャ別(E-UTRAN、EPC)、サービス別(コンサルティング、統合)、展開モデル別(プライベート、ハイブリッド)、用途別(法執行、消防サービス)、地域別“The PS-LTE market is projected to grow at a CAGR of 20.2% from 2019 to 2024.” The PS-LTE market is projected to grow from USD 4.7 billion in 2019 to USD 11.7 billion by 2024; it is expected to grow at a CAGR of 20.2% from 2019 to 2024. The adoption of LTE technology to eliminate the existing interconnectivity issues between different networks, increase in demand for unmanned vehicles globally, an …
- 糖鎖生物学グライコミクス/グリコバイオロジーの世界市場予測(~2021):製品別(酵素(グリコシルトランスフェラーゼ、グリコシダーゼ)、機器別(高速液体クロマトグラフィー(HPLS)、質量分析、マトリックス支援レーザー脱離イオン化-飛行時間型質量分析(MALDITOF))、キットおよび試薬別(糖タンパク質))、用途別(診断、創薬、腫瘍学)、エンドユーザー 別The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotech …
- BaaS(サービスとしてのバイオメトリクス)の世界市場予測(~2022年)The growing demand for biometric authentication under various government initiatives and regulations has fueled the adoption of biometrics-as-a-service solutionsThe global biometrics-as-a-service market is expected to grow from USD 838.0 million in 2017 to USD 2972.8 million by 2022, at a Compound Annual Growth Rate (CAGR) of 28.82%. There is an increasing need for biometrics solutions for identif …
- 垂直農法の世界市場:コンポーネント別、構造別、成長メカニズム別The global vertical farming market size was valued at $2.23 billion in 2018, and is projected to reach $12.77 billion by 2026, growing at a CAGR of 24.6% from 2019 to 2026. Vertical farming is a non-traditional method to grow crops, which enables ease of harvesting, no effect of climate, high yield, minimal usage of pesticides, less area requirement, and less water consumption. For instance, one h …
- 事業提携・ライセンシング・投資・M&A動向:July 2013(製薬業界)Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de …
- ぶどう膜炎(Uveitis)のグローバル市場動向(2014-2018)About Uveitis Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body. Infections, injury and autoimmune disorders may be related with the development of uveitis; however, the exact cause is often unknown. Various types of uveitis are: anterior uveitis, intermediate uveitis, posterio …
- パッケージ・コーディング及びマーキングの世界市場About Coding and Marking Coding and marking equipment/products are used to print product-specific details on the product itself in order to provide authentic information to users as well as manufacturers. The printing of codes on the products includes manufacturing date, expiry date, lot size and number, and other specific details. The codes/marks printed on the products are helpful to the manufac …
- 構造的心疾患治療器具の世界市場2018-2022About Structural Heart Disease Treatment Devices Global structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart. Technavio’s analysts forecast the Global Structural Heart Disease Treatment Devices Market to grow at a CAGR of …
- 分光分析装置の世界市場:エネルギー分散型X線分光器(EDS)、波長分散型X線分光器(WDS)、電子線後方散乱回折(EBSD) 分析装置、マイクロ蛍光X線分析(マイクロXRF)装置The EDS, WDS, EBSD, and micro-XRF instruments market has registered constant growth over the years. Factors such as the growing semiconductors industry, increasing demand for nanotechnology, demand for automobiles, and technological advancements are propelling the growth of this market. The semiconductors industry is experiencing a robust growth globally. This industry witnessed a growth of 11.5% …
- 世界のエンジニアリングウッド製品市場2015The Global Engineered Wood Product Industry Report 2015 is a professional and in-depth study on the current state of the Engineered Wood Product industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Engineered Wood Product market analysis is provided for the international markets including development tr …
- 世界の蛋白質(プロテイン)結晶生成市場動向及び予測(~2018):技術別、製品別、エンドユーザーザ別分析Increase in Government-funded Research and Continued Funding by the PSI Ensure Continued Development of New Technologies Protein crystallization & crystallography are techniques that are used very frequently by researchers to understand the three-dimensional structure of a protein. The market for protein crystallization & crystallography is expected to grow at a high rate owing to its huge potenti …
- レーザー育毛治療の世界市場2018-2022About Laser Hair Loss Treatment Laser devices used for hair loss treatments are non-invasive treatment devices. These devices use low level lasers technology (LLLT) for hair loss treatments. These are also known as soft lasers or cold lasers. These lasers penetrate the scalp and stimulate the roots of hair, which increases blood circulation and stimulates hair growth. Technavio’s analysts forecast …
- ダークチョコレートの世界市場2015-2019About Dark Chocolate Dark chocolate is made from cocoa butter, sugar, and cocoa powder, with very little or no milk. Dark chocolates are considered very beneficial for health. The introduction of new varieties has increased sales. New varieties contain ingredients such as dry fruits, toffee, and sea salt. Increased demand for dark chocolate in developing countries is a result of rise in income lev …